Anti-IFN-I autoantibodies can be found in patients treated with IFN-a or IFN-β (40) and exist in almost all patients with autoimmune polyendocrine syndrome type-1 (APS-1) (41). This evidence concerns the gene IFNA1 and autoimmune polyendocrine syndrome type 1.